1. Home
  2. FUSB vs HRTX Comparison

FUSB vs HRTX Comparison

Compare FUSB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First US Bancshares Inc.

FUSB

First US Bancshares Inc.

HOLD

Current Price

$16.49

Market Cap

91.4M

Sector

Finance

ML Signal

HOLD

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

HOLD

Current Price

$0.31

Market Cap

90.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSB
HRTX
Founded
1952
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.4M
90.1M
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
FUSB
HRTX
Price
$16.49
$0.31
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
34.3K
2.9M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
N/A
$154,904,000.00
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
$25.80
N/A
Revenue Growth
N/A
7.36
52 Week Low
$10.81
$0.30
52 Week High
$16.99
$1.58

Technical Indicators

Market Signals
Indicator
FUSB
HRTX
Relative Strength Index (RSI) 50.20 32.10
Support Level $15.75 N/A
Resistance Level $16.88 $0.46
Average True Range (ATR) 0.22 0.03
MACD -0.01 -0.00
Stochastic Oscillator 62.32 10.05

Price Performance

Historical Comparison
FUSB
HRTX

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement accounts, and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: